Preparing a drug registration for the US and the EU: Parallel or sequential applications? – Part 1

Regulatory approval and market access: A winning combination for drug launch optimization

Preparing a drug registration for the US and the EU: Parallel or sequential applications? – Part 2

Obtaining orphan status – A key milestone within a development strategy

Modern Technology Transfer Strategies for Biopharmaceutical Companies

Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches: features and perspectives

Market Access in Europe: Bridging Regulatory and Health Technology Assessment (HTA) Gaps